Andrx, Sciele Sue Lupin Over Diabetes Drug ANDA

Law360, New York (January 16, 2009, 12:00 AM EST) -- Andrx Corp. and Sciele Pharma Inc. have accused Lupin Ltd. of infringing two patents related to type 2 diabetes treatment Fortamet after Lupin sought approval to make a generic version of the pill prior to the expiration of the patents.

Andrx, which own the patents-in-suit, and Sciele, which licenses the patents, sued Lupin and its subsidiary, Lupin Pharmaceuticals Inc., in the U.S District Court for the District of Delaware on Thursday, weeks after learning that Lupin had submitted an abbreviated new drug application to the U.S....
To view the full article, register now.